Ultragenyx Pharmaceutical Inc. ( RARE ) was a big mover last session with its shares rising 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend of the company, as the stock has lost over 22% since March 19.
This biotechnology company has witnessed one negative estimate revision in the last 30 days. The Zacks Consensus Estimate has also moved lower over the same period. This implies trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday's rally can last.
Ultragenyx currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
Investors interested in the biomedical industry may consider better-ranked stocks like Alexion Pharmaceuticals, Inc. ( ALXN ), Gilead Sciences Inc. ( GILD ) and Actelion Ltd. ( ALIOF ). All the three stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>